Treatment of NSCLC cell lines A549 and H520 with IL-17 resulted in increased phosphorylation of STAT3, which upregulated prometastatic factor production including vascular endothelial growth factor (VEGF) [105]. Here, VEGFA is linked to non-small cell lung carcinoma.